PRIMARY STUDY

Palmitoylethanolamide as adjunctive therapy for autism: Efficacy and safety results from a randomized controlled trial

Key Findings:  Resulting data suggests that the use of PEA may produce a synergy with risperidone on autism-related irritability and hyperactivity potentially via its ability to reduce inflammation and glutamate excitotoxicity.